As we work to fulfil our mission to help adult smokers switch from combustible cigarettes, JUUL Labs is committed to both conducting and supporting durably designed, painstakingly executed preclinical, clinical, and behavioural research examining the public health impact of our products. We occupy a unique space in this industry as we seek to completely eliminate combustible cigarettes by providing smokers an alternative nicotine delivery system.
For the full story, please visit our US Newsroom at newsroom.juul.com
April 27, 2021
Juul Labs’ Chief Regulatory Officer, Joe Murillo, published a piece entitled “Juul Labs: Advancing the Scientific Dialogue About Tobacco Harm Reduction” in the Food & Drug Law Institute (FDLI) newsletter.
April 26, 2021
Juul Labs is committed to working collaboratively with regulators, policymakers, public health leaders, and other stakeholders as we work to reset the category and…
February 11, 2021
As we continue to do our part to support enforcement against black-market vapor products in the United States and abroad, Juul Labs is pleased…